Transmedics Group Inc (NASDAQ: TMDX) is -22.87% lower on its value in year-to-date trading and has touched a low of $60.80 and a high of $177.37 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TMDX stock was last observed hovering at around $65.71 in the last trading session, with the day’s loss setting it -4.83%.
Currently trading at $60.88, the stock is -16.37% and -34.11% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.59 million and changing -7.34% at the moment leaves the stock -49.69% off its SMA200. TMDX registered -20.80% loss for a year compared to 6-month loss of -57.72%. The firm has a 50-day simple moving average (SMA 50) of $93.9436 and a 200-day simple moving average (SMA200) of $121.112076.
The stock witnessed a -24.77% gain in the last 1 month and extending the period to 3 months gives it a -63.32%, and is -9.62% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.28% over the week and 6.18% over the month.
Transmedics Group Inc (TMDX) has around 584 employees, a market worth around $2.04B and $401.09M in sales. Current P/E ratio is 65.22 and Fwd P/E is 41.76. Profit margin for the company is 8.14%. Distance from 52-week low is 0.13% and -65.68% from its 52-week high. The company has generated returns on investments over the last 12 months (4.50%).
The EPS is expected to grow by 226.39% this year
502.0 institutions hold shares in Transmedics Group Inc (TMDX), with institutional investors hold 116.69% of the company’s shares. The shares outstanding are 33.56M, and float is at 32.43M with Short Float at 28.65%. Institutions hold 112.94% of the Float.
The top institutional shareholder in the company is FMR LLC with over 4.49 million shares valued at $676.31 million. The investor’s holdings represent 13.7063 of the TMDX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 2.65 million shares valued at $398.47 million to account for 8.0755 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 2.53 million shares representing 7.7118 and valued at over $380.53 million, while DRIEHAUS CAPITAL MANAGEMENT LLC holds 4.5362 of the shares totaling 1.49 million with a market value of $223.83 million.
Transmedics Group Inc (TMDX) Insider Activity
The most recent transaction is an insider sale by Khayal Tamer I, the company’s Chief Commercial Officer. SEC filings show that Khayal Tamer I sold 1,084 shares of the company’s common stock on Dec 02 ’24 at a price of $86.40 per share for a total of $93658.0. Following the sale, the insider now owns 20843.0 shares.
Transmedics Group Inc disclosed in a document filed with the SEC on Nov 11 ’24 that Khayal Tamer I (Chief Commercial Officer) sold a total of 1,458 shares of the company’s common stock. The trade occurred on Nov 11 ’24 and was made at $90.04 per share for $0.13 million. Following the transaction, the insider now directly holds 20843.0 shares of the TMDX stock.
Still, SEC filings show that on Nov 05 ’24, Basile Edward M (Director) disposed off 6,750 shares at an average price of $83.55 for $0.56 million. The insider now directly holds 732 shares of Transmedics Group Inc (TMDX).
